Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne L Miller

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Circulation. Heart Failure|February 5, 2011
Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failureWayne L Miller, Mary A Phelps, Christina M Wood, et al.
The Journal of Biological Chemistry|May 3, 2006
Structural studies of FlaA1 from Helicobacter pylori reveal the mechanism for inverting 4,6-dehydratase activityNoboru Ishiyama, Carole Creuzenet, Wayne L Miller, et al.
The International Journal of Cardiovascular Imaging|February 26, 2015
Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CTWayne L Miller, Thomas R Behrenbeck, Cynthia H McCollough, et al.
Annals of Biomedical Engineering|November 16, 2013
Early changes in myocardial microcirculation in asymptomatic hypercholesterolemic subjects: as detected by perfusion CTThomas R Behrenbeck, Cynthia H McCollough, Wayne L Miller, et al.
The American Journal of Cardiology|July 21, 2010
Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failureLinnea M Baudhuin, Wayne L Miller, Laura Train, et al.
Applied and Environmental Microbiology|January 15, 2013
Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureusRoderick A MacPhee, Wayne L Miller, Gregory B Gloor, et al.
American Heart Journal|August 30, 2003
Baseline comorbidities and treatment strategy in elderly patients are associated with outcome of cardiogenic shock in a community-based populationJames V Tedesco, Brent A Williams, R Scott Wright, et al.
Mayo Clinic Proceedings|May 15, 2003
Effect of diabetes on the mortality risk of cardiogenic shock in a community-based populationJames V Tedesco, R Scott Wright, Brent A Williams, et al.
Circulation|May 24, 2019
Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection FractionGiovanni Benfari, Clemence Antoine, Wayne L Miller, et al.
Circulation|June 27, 2007
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over timeWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Circulation. Heart Failure|February 5, 2011
Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failureWayne L Miller, Mary A Phelps, Christina M Wood, et al.
The Journal of Biological Chemistry|May 3, 2006
Structural studies of FlaA1 from Helicobacter pylori reveal the mechanism for inverting 4,6-dehydratase activityNoboru Ishiyama, Carole Creuzenet, Wayne L Miller, et al.
The International Journal of Cardiovascular Imaging|February 26, 2015
Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CTWayne L Miller, Thomas R Behrenbeck, Cynthia H McCollough, et al.
Annals of Biomedical Engineering|November 16, 2013
Early changes in myocardial microcirculation in asymptomatic hypercholesterolemic subjects: as detected by perfusion CTThomas R Behrenbeck, Cynthia H McCollough, Wayne L Miller, et al.
The American Journal of Cardiology|July 21, 2010
Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failureLinnea M Baudhuin, Wayne L Miller, Laura Train, et al.
Applied and Environmental Microbiology|January 15, 2013
Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureusRoderick A MacPhee, Wayne L Miller, Gregory B Gloor, et al.
American Heart Journal|August 30, 2003
Baseline comorbidities and treatment strategy in elderly patients are associated with outcome of cardiogenic shock in a community-based populationJames V Tedesco, Brent A Williams, R Scott Wright, et al.
Mayo Clinic Proceedings|May 15, 2003
Effect of diabetes on the mortality risk of cardiogenic shock in a community-based populationJames V Tedesco, R Scott Wright, Brent A Williams, et al.
Circulation|May 24, 2019
Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection FractionGiovanni Benfari, Clemence Antoine, Wayne L Miller, et al.
Circulation|June 27, 2007
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over timeWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Pageof 11